Free Trial

AstraZeneca (AZN) SEC Filings & 10K Form

$83.05
+0.05 (+0.06%)
(As of 09/6/2024 ET)

Recent AstraZeneca SEC Filings

DateFilerForm TypeView
09/03/2024
5:05 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/16/2024
5:21 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
9:11 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2024
5:26 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2024
5:00 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/26/2024
5:42 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2024
8:06 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2024
5:15 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2024
9:07 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2024
5:07 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2024
4:00 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/25/2024
5:12 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
5:07 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2024
5:38 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2024
5:21 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2024
9:14 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2024
9:02 AM
AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
06/03/2024
9:23 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
9:29 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
5:35 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
5:15 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
5:08 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/20/2024
5:32 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
5:41 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2024
9:09 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
6:31 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2024
5:49 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
6:18 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
5:52 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
5:26 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
12:22 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
5:55 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
5:14 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
5:14 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/05/2024
5:22 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2024
7:45 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2024
6:54 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2024
6:28 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2024
4:27 PM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Fusion Pharmaceuticals Inc. (Subject)
Form DFAN14A
03/19/2024
3:31 PM
AstraZeneca Finance LLC (Filer)
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form F-3ASR
03/19/2024
5:02 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
War on Elon Escalates… (Ad)

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.
03/14/2024
6:12 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2024
6:29 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2024
5:30 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2024
5:34 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2024
9:06 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2024
9:11 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2024
6:21 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form CERT
03/05/2024
3:40 PM
AstraZeneca Finance LLC (Filer)
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 8-A12B
03/04/2024
5:33 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/01/2024
9:39 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2024
5:19 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/22/2024
8:14 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/22/2024
8:19 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/22/2024
5:08 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2024
7:32 AM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
Form SC TO-T/A
02/21/2024
7:13 AM
AstraZeneca Finance LLC (Filer)
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
02/21/2024
5:04 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
8:25 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
6:51 AM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
Form SC TO-T/A
02/20/2024
6:49 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
6:12 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
5:52 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
5:47 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
5:27 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2024
9:13 AM
ADC Therapeutics SA (Subject)
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Form SC 13G/A
02/08/2024
5:40 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/01/2024
9:30 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/24/2024
4:23 PM
AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/19/2024
7:46 AM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
Form SC TO-T/A
01/19/2024
7:31 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/10/2024
7:39 PM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
Form SC TO-T/A
01/02/2024
9:53 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2023
7:03 AM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
Form SC TO-T
12/27/2023
6:09 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/26/2023
4:25 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/22/2023
5:19 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/14/2023
9:20 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2023
4:15 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2023
4:15 PM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
Form SC TO-C
12/12/2023
5:26 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/01/2023
10:50 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/01/2023
10:53 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/01/2023
5:26 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/24/2023
6:11 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/17/2023
5:36 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/16/2023
10:16 AM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Cellectis S.A. (Subject)
Form SC 13D/A
11/14/2023
5:39 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2023
7:19 AM
AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
SARIN ARADHANA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/09/2023
9:01 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/09/2023
9:05 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Ex-CIA Advisor: “This is How Kamala will Rig the Election” (Ad)

A former CIA advisor with close ties to the White House… Has just released this shocking expose on Kamala’s plan to stop Trump. Every American needs to prepare now…

Click here now and learn how to prepare.
11/09/2023
8:49 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/09/2023
8:57 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2023
11:24 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2023
5:38 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/03/2023
6:36 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/03/2023
6:36 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/02/2023
9:27 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2023
11:49 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2023
5:55 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:AZN) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners